Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
Open Access
- 11 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (11), 1618-1626
- https://doi.org/10.1038/sj.bjc.6605689
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infectionBMC Cancer, 2009
- Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinomaInternational Journal of Cancer, 2009
- Targeting Stem Cells-Clinical Implications for Cancer TherapyCurrent Stem Cell Research & Therapy, 2009
- Liver Resection with Portal Vein Thrombectomy for Hepatocellular Carcinoma With Vascular InvasionAnnals of Surgical Oncology, 2009
- Effects of the sesquiterpene lactone parthenolide on prostate tumor‐initiating cells: An integrated molecular profiling approachThe Prostate, 2009
- EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular CarcinomaCancer Research, 2008
- Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.2006
- Early and Late Recurrence After Liver Resection for Hepatocellular CarcinomaAnnals of Surgery, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Solitary fibrous tumor of the liver with CD 34 positivity and hypoglycemia.Journal of Hepato-Biliary-Pancreatic Surgery, 1998